Resources from the same session
1016O - Autoimmunity against surfactant protein B drives immune checkpoint inhibitor-related pneumonitis in patients with NSCLC
Presenter: Lukas Flatz
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Invited Discussant 1016O
Presenter: Gary Middleton
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Webcast
1017O - NTC-001: A phase I study to test safety and efficacy of BNT221, a non-engineered neoantigen-specific T cell product, in patients with advanced or metastatic melanoma
Presenter: Jessica Borgers
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1018O - Phase I study of GCC CAR-T therapy IM96 in patients with advanced colorectal cancer
Presenter: Changsong Qi
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1019O - Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors
Presenter: Victor Moreno Garcia
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Webcast